Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.

Por Gras, L., Gilbert, R. E., Wallon, M., Peyron, F., Cortina-Borja, M.
Publicado em 2004

Impact of Spiramycin Treatment and Gestational Age on Maturation of Toxoplasma gondii Immunoglobulin G Avidity in Pregnant Women

Por Lefevre-Pettazzoni, M., Bissery, A., Wallon, M., Cozon, G., Peyron, F., Rabilloud, M.
Publicado em 2007

Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

Por Binquet, C., Wallon, M., Quantin, C., Kodjikian, L., Garweg, J., Fleury, J., Peyron, F., Abrahamowicz, M.
Publicado em 2003

A switch towards Th2 during serological rebound in children with congenital toxoplasmosis

Por Kahi, S, Cozon, G J N, Pinon, J M, Greenland, T, Wallon, M, Al Kurdi, M, Ferrandiz, J, Peyron, F
Publicado em 1999

Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol.

Por Gilbert, R., Dunn, D., Wallon, M., Hayde, M., Prusa, A., Lebech, M., Kortbeek, T., Peyron, F., Pollak, A., Petersen, E.
Publicado em 2001